 Home > Active Ingredient News > Immunology News > Targeting a new nanoantibody for ADAMTS5 osteoarthritis, Merck awarded it to Novartis for 50 million euros.

Targeting a new nanoantibody for ADAMTS5 osteoarthritis, Merck awarded it to Novartis for 50 million euros.

 Last Update: 2020-10-21
 Source: Internet
 Author: User

Tags

pathology osteoarthritis

reasons joint pain

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Merck KGaA has signed a licensing agreement with Novartis to develop clinical studies of osteoarthritis drugs.
protocol covers the phase II clinical anti-ADAMTS5n antibody M6495, a drug developed for patients to inject themselves under the skin to maintain the structural integrity of the knee joint and reduce pain.
has completed two Phase I studies of M6495: one in healthy volunteers showing safety and tolerance, and the other observing a significant decrease in ANGS, a new cousin found in the fluid and serum of osteoarthritis patients.
photo source: 2019 ACR/ARP Annual Meeting Osteoarthritis is a chronic progressive disease characterized by the degression of joint cartilage.
metal protease ADAMTS5 is the main cause of cartilage degradation in arthritis disease.
: Under the terms of the deal, Merck will license the M6495 to Novartis for further evaluation of osteoarthritis patients.
, Merck will receive an advance of 50 million euros and possibly another 400 million euros related to business milestones and sales royalties.
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.